Stereotaxis, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Stereotaxis, Inc. on December 21, 2010, reporting events that occurred on December 17, 2010. The filing details the entry into material definitive agreements regarding the company's debt financing and the issuance of equity warrants.
Key Financial Metrics and Agreements
The filing outlines a Second Loan Modification Agreement with Silicon Valley Bank (SVB) and an Export-Import Bank Second Loan Modification Agreement. Key financial terms include:
- Revolving Line of Credit: Extended maturity date to March 31, 2012. Maximum credit availability is $30 million, including a $10 million sublimit backed by investor guarantees from Alafi Capital Company LLC and affiliates of Sanderling Venture Partners.
- New Term Loan: An additional $10 million term loan was secured, maturing on December 31, 2013.
- Interest Rate: The Term Loan accrues interest at the Prime Rate plus 3.50% per annum.
- Repayment Terms: Interest is payable monthly. Principal repayment begins July 1, 2011, in 30 equal monthly installments.
- Equity Issuance: The company granted SVB a warrant to purchase 111,111 shares of common stock at an exercise price of $3.60 per share, expiring December 17, 2015.
Material Changes and Covenants
The agreements modify the company's financial covenants and reporting requirements:
- Tangible Net Worth: Reporting frequency for tangible net worth requirements changes from monthly to quarterly, effective December 31, 2010.
- Liquidity Ratio: The company must maintain a liquidity ratio of no less than 1.25:1 during March, June, September, and December, and no less than 1.50:1 during all other months.
- Ex-Im Loan: The Export-Import Bank agreement was amended to reflect the extension of the revolving line of credit maturity date.
Outlook, Risks, and Unusual Items
The filing does not provide specific revenue guidance, profit outlook, or management commentary regarding future operational performance. The primary focus is on the restructuring of debt obligations to extend liquidity and modify covenant compliance schedules. The issuance of the warrant was conducted under Section 4(2) of the Securities Act of 1933 and Rule 506 of Regulation D, relying on exemptions for private offerings to accredited investors.
Investor Verification Checklist
- Verify the company's current cash position against the new liquidity ratio covenants (1.25:1 or 1.50:1).
- Confirm the status of the $10 million investor guarantees provided by Alafi Capital and Sanderling Venture Partners.
- Review the impact of the new $10 million term loan on future cash flow, specifically the principal payments starting July 2011.
- Assess the potential dilution from the warrant issuance (111,111 shares at $3.60).
- Monitor compliance with the new quarterly tangible net worth reporting schedule.